Colin Sims

Accuray (United States)

Papers

1

Total Citations

55

H-Index

1

About

Dr. Colin Sims is a leading medical physicist whose research focuses on advancing precision radiotherapy, particularly through the integration of robotic delivery systems and sophisticated collimation technologies. His most influential work, a 2015 study with 55 citations, investigates the clinical advantages of a robotic linear accelerator equipped with a multileaf collimator (MLC) for treating brain and prostate cancer patients. This landmark paper systematically evaluated the CyberKnife system’s performance in stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT), demonstrating how MLC-enhanced robotic platforms can improve dose conformity and treatment efficiency. By quantifying the benefits of this hybrid approach, Dr. Sims has helped bridge the gap between robotic radiosurgery and conventional fractionated therapy, offering clinicians evidence-based guidance for optimizing patient outcomes. His contributions are particularly valuable in the context of prostate and intracranial cancers, where precise dose delivery is critical. With a citation record that underscores the practical impact of his work, Dr. Sims continues to shape the evolution of adaptive and automated radiotherapy, making him a key figure in the translation of engineering innovations into tangible clinical benefits.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients
55 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Accuray (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago